{"title":"成人肺炎球菌疫苗接种:如何提高疫苗接种覆盖率?","authors":"T. Goulenok","doi":"10.1016/j.antinf.2014.01.007","DOIUrl":null,"url":null,"abstract":"<div><p>La vaccination est l’une des interventions de prévention les plus efficaces et les plus sûres. Les autorités de santé en sont convaincues, comme en témoignent les dernières recommandations. Pourtant, la couverture vaccinale est insuffisante, notamment en France. L’exemple de la vaccination anti-pneumococcique est ici analysé afin de mettre en évidence les freins et les moyens d’amélioration de la couverture vaccinale.</p></div><div><p>Immunization is one of the most efficient preventive action. Health authorities are convinced of this priority, as it is shown in the recent recommandations. Nevertheless, the vaccine coverage rate is low, particularly in France. The pneumococcal vaccine is taken as an analysis to explain barriers and opportunities for immunization.</p></div>","PeriodicalId":49043,"journal":{"name":"Journal Des Anti-Infectieux","volume":"16 2","pages":"Pages 89-98"},"PeriodicalIF":0.0000,"publicationDate":"2014-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.antinf.2014.01.007","citationCount":"4","resultStr":"{\"title\":\"Vaccination anti-pneumococcique chez l’adulte : comment améliorer la couverture vaccinale ?\",\"authors\":\"T. Goulenok\",\"doi\":\"10.1016/j.antinf.2014.01.007\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>La vaccination est l’une des interventions de prévention les plus efficaces et les plus sûres. Les autorités de santé en sont convaincues, comme en témoignent les dernières recommandations. Pourtant, la couverture vaccinale est insuffisante, notamment en France. L’exemple de la vaccination anti-pneumococcique est ici analysé afin de mettre en évidence les freins et les moyens d’amélioration de la couverture vaccinale.</p></div><div><p>Immunization is one of the most efficient preventive action. Health authorities are convinced of this priority, as it is shown in the recent recommandations. Nevertheless, the vaccine coverage rate is low, particularly in France. The pneumococcal vaccine is taken as an analysis to explain barriers and opportunities for immunization.</p></div>\",\"PeriodicalId\":49043,\"journal\":{\"name\":\"Journal Des Anti-Infectieux\",\"volume\":\"16 2\",\"pages\":\"Pages 89-98\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2014-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.antinf.2014.01.007\",\"citationCount\":\"4\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal Des Anti-Infectieux\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2210654514000088\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal Des Anti-Infectieux","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2210654514000088","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
Vaccination anti-pneumococcique chez l’adulte : comment améliorer la couverture vaccinale ?
La vaccination est l’une des interventions de prévention les plus efficaces et les plus sûres. Les autorités de santé en sont convaincues, comme en témoignent les dernières recommandations. Pourtant, la couverture vaccinale est insuffisante, notamment en France. L’exemple de la vaccination anti-pneumococcique est ici analysé afin de mettre en évidence les freins et les moyens d’amélioration de la couverture vaccinale.
Immunization is one of the most efficient preventive action. Health authorities are convinced of this priority, as it is shown in the recent recommandations. Nevertheless, the vaccine coverage rate is low, particularly in France. The pneumococcal vaccine is taken as an analysis to explain barriers and opportunities for immunization.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
